BARCELONA, Spain and DÜSSELDORF, Germany, July 24, 2026 -- Minoryx Therapeutics and Neuraxpharm Group, announce that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has...
Arthur Klausner to speak at the 13th Annual Drug Discovery & Development of Innovative Therapeutics (DDT) in Boston, MA
News | 08. 04. 2008
